TY  - JOUR
AU  - Ayala de la Peña, F
AU  - Ortiz-Muñoz, B
AU  - Quintanar-Verdúguez, T
AU  - Santotoribio, J D
AU  - de la Cruz, S
AU  - Trapé-Pujol, J
AU  - Galve-Calvo, E
AU  - Augé-Fradera, J M
AU  - García-Gómez, J
AU  - González-Hernández, Á
PY  - 2021
DO  - 10.1007/s12094-020-02529-x
UR  - http://hdl.handle.net/10668/17116
T2  - Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico
AB  - The measurement of circulating tumour markers (TMs) for the diagnosis or monitoring of breast cancer has sometimes been considered of limited utility. In addition to the overinterpretation of irrelevant changes in marker levels, the characteristics of...
LA  - en
KW  - Biomarkers
KW  - Breast neoplasms
KW  - Carcinoembryonic antigen
KW  - Tumor suppressor
KW  - p53
KW  - Biomarkers, Tumor
KW  - Breast Neoplasms
KW  - Female
KW  - Hematologic Tests
KW  - Humans
TI  - Consensus of the Spanish society of laboratory medicine and the Spanish society of medical oncology on the methodology and criteria for evaluation of circulating tumour markers in breast cancer.
TY  - research article
VL  - 23
ER  -